|Videos|December 20, 2019
Management of HER2 Expression in Breast Cancer
Author(s)Sponsored Content
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer
2
FDA Approves Ibrance Combo for Maintenance Treatment of HR-Positive, HER2-Positive Metastatic Breast Cancer
3
The Life I Did Not Expect After Cancer
4
The Heart of an Oncology Office
5